YTHDC2 and colorectal cancer: Furthermore, downregulation of the RNA methylation regulator YTHDC2 has been associated with cuproptosis resistance in colorectal cancer, with YTHDC2 knockdown attenuating the anti-tumorigenic effects of elesclomol-Cu (Shen et al., 2023; Zhao et al., 2024) (Table 1).